BOK Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
3,148
+8
+0.3% +$2.97K 0.02% 406
2026
Q1
$919K Buy
3,140
+199
+7% +$65.4K 0.01% 438
2025
Q4
$1.03M Sell
2,941
-4,704
-62% -$1.59M 0.02% 420
2025
Q3
$2.47M Sell
7,645
-1,237
-14% -$385K 0.04% 311
2025
Q2
$3.45M Buy
8,882
+772
+10% +$311K 0.06% 255
2025
Q1
$3.53M Sell
8,110
-1,476
-15% -$593K 0.06% 241
2024
Q4
$3.65M Sell
9,586
-1,085
-10% -$454K 0.06% 229
2024
Q3
$5.32M Sell
10,671
-265
-2% -$142K 0.09% 184
2024
Q2
$5.93M Sell
10,936
-5,699
-34% -$3.01M 0.11% 177
2024
Q1
$8.58M Sell
16,635
-4,746
-22% -$2.36M 0.16% 141
2023
Q4
$10.1M Sell
21,381
-59
-0.3% -$27.3K 0.2% 106
2023
Q3
$9.65M Sell
21,440
-3,123
-13% -$1.42M 0.21% 105
2023
Q2
$10.9M Buy
24,563
+1,915
+8% +$883K 0.22% 105
2023
Q1
$10.4M Sell
22,648
-2,165
-9% -$1.03M 0.22% 108
2022
Q4
$12.7M Sell
24,813
-11,546
-32% -$5.86M 0.23% 96
2022
Q3
$16.5M Sell
36,359
-1,784
-5% -$854K 0.33% 71
2022
Q2
$18.4M Buy
38,143
+627
+2% +$310K 0.35% 69
2022
Q1
$18.4M Sell
37,516
-2,285
-6% -$1.04M 0.3% 75
2021
Q4
$18.4M Buy
39,801
+7,043
+22% +$2.96M 0.29% 82
2021
Q3
$12.2M Buy
+32,758
New +$12.4M 0.21% 107
2021
Q1
$10.6M Sell
29,583
-2,556
-8% -$822K 0.19% 117
2020
Q4
$10.3M Buy
32,139
+3,933
+14% +$1.21M 0.2% 114
2020
Q3
$7.58M Buy
28,206
+2,883
+11% +$776K 0.17% 133
2020
Q2
$6.66M Buy
25,323
+85
+0.3% +$22.7K 0.16% 146
2020
Q1
$5.73M Buy
25,238
+8,717
+53% +$2.38M 0.17% 133
2019
Q4
$4.99M Buy
16,521
+502
+3% +$138K 0.11% 194
2019
Q3
$3.85M Sell
16,019
-4,003
-20% -$1.1M 0.09% 229
2019
Q2
$5.65M Sell
20,022
-14,238
-42% -$3.89M 0.14% 178
2019
Q1
$9.83M Buy
34,260
+1,435
+4% +$415K 0.24% 102
2018
Q4
$8.62M Sell
32,825
-2,644
-7% -$727K 0.25% 99
2018
Q3
$9.72M Sell
35,469
-973
-3% -$253K 0.24% 97
2018
Q2
$8.67M Sell
36,442
-1,416
-4% -$328K 0.23% 102
2018
Q1
$8.32M Sell
37,858
-4,772
-11% -$1.12M 0.24% 101
2017
Q4
$9.59M Sell
42,630
-10,720
-20% -$2.28M 0.26% 92
2017
Q3
$10.1M Sell
53,350
-6,253
-10% -$1.19M 0.29% 83
2017
Q2
$11.2M Buy
59,603
+784
+1% +$141K 0.35% 73
2017
Q1
$9.73M Buy
58,819
+14,198
+32% +$2.26M 0.3% 80
2016
Q4
$6.42M Buy
44,621
+2,456
+6% +$329K 0.21% 112
2016
Q3
$5.28M Buy
42,165
+28,342
+205% +$3.66M 0.17% 129
2016
Q2
$1.82M Buy
13,823
+2,714
+24% +$371K 0.06% 321
2016
Q1
$1.54M Sell
11,109
-7,958
-42% -$1.06M 0.06% 340
2015
Q4
$2.66M Sell
19,067
-12,861
-40% -$1.77M 0.1% 250
2015
Q3
$4.47M Buy
31,928
+1,443
+5% +$217K 0.17% 147
2015
Q2
$5M Buy
30,485
+43
+0.1% +$6.87K 0.17% 134
2015
Q1
$4.7M Sell
30,442
-5,992
-16% -$853K 0.16% 151
2014
Q4
$4.58M Sell
36,434
-9,244
-20% -$1.14M 0.16% 146
2014
Q3
$5.46M Buy
45,678
+5,407
+13% +$620K 0.18% 125
2014
Q2
$4.33M Sell
40,271
-4,701
-10% -$484K 0.14% 168
2014
Q1
$4.48M Buy
44,972
+40,090
+821% +$3.63M 0.15% 153
2013
Q4
$451K Buy
4,882
+265
+6% +$23.5K 0.02% 649
2013
Q3
$386K Buy
4,617
+1,227
+36% +$105K 0.01% 638
2013
Q2
$278K Buy
+3,390
New +$254K 0.01% 693

Other funds holding ELV

BOK Financial's ELV Position: Q2 2026 in Review

BOK Financial increased its Elevance Health (ELV) stake by 0.25% in Q2 2026, buying an estimated $2.97K and bringing the position to 3,148 shares worth $1.22M. The position accounts for 0.02% of the portfolio, ranked #406.

BOK Financial first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.4M in Q4 2021. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • BOK Financial held 3,148 shares of Elevance Health worth $1.22M as of Q2 2026.
  • BOK Financial bought 8 Elevance Health shares in Q2 2026, an estimated $2.97K.
  • Elevance Health made up 0.02% of BOK Financial's portfolio in Q2 2026, its #406 holding.
  • BOK Financial first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • BOK Financial's Elevance Health position peaked at $18.4M in Q4 2021.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.